Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Public ClinicalTrials.gov record NCT06476132. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients: A Randomized, Multicenter, Double Blind, Placebo-Controlled Trial (CTOT-47)
Study identification
- NCT ID
- NCT06476132
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 234 participants
Conditions and interventions
Conditions
Interventions
- Belumosudil Drug
- Placebo for Belumosudil Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 11, 2025
- Primary completion
- May 29, 2027
- Completion
- Jun 29, 2027
- Last update posted
- May 11, 2026
2025 – 2027
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Los Angeles (Site #: 71123) | Los Angeles | California | 90095 | Recruiting |
| Stanford University (Site #: 71141) | Palo Alto | California | 94304 | Recruiting |
| Johns Hopkins (Site #: 71119) | Baltimore | Maryland | 21287 | Recruiting |
| University of Minnesota (Site 71151) | Minneapolis | Minnesota | 55455 | Recruiting |
| Washington University (Site #: 71157) | St Louis | Missouri | 63130 | Recruiting |
| NYU Langone Health (Site #: 71177) | New York | New York | 10016 | Recruiting |
| Duke University (Site #: 71139) | Durham | North Carolina | 27710 | Recruiting |
| Cincinnati Children's Hospital Medical Center (Site #: 71017) | Cincinnati | Ohio | 45229 | Recruiting |
| Cleveland Clinic (Site #: 71101) | Cleveland | Ohio | 44195 | Recruiting |
| University of Pennsylvania (Site #: 71111) | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Vanderbilt University Medical Center (Site #: 71174) | Nashville | Tennessee | 37232 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06476132, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06476132 live on ClinicalTrials.gov.